$MNKD MannKind Corp. Closes Below Vital Support
publication date: Feb 2, 2011
MannKind Corp. (NASDAQ:MNKD), closed at 4.74, down 0.63%. In the past two weeks, the stock has lost nearly 53% of its entire value due to the delivery of a complete response letter from the FDA regarding its new drug, AFREZZA, which is in inhalation powder intended to treat type 1 and 2 diabetes.